Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.

OBJECTIVE: Despite the clinical importance of an accurate diagnosis in individuals with monogenic forms of diabetes, restricted access to genetic testing leaves many patients with undiagnosed diabetes. Recently, common variation near the HNF1 homeobox A (HNF1A) gene was shown to influence C-reactive...

Bibliográfalaš dieđut
Váldodahkkit:	Owen, K, Thanabalasingham, G, James, T, Karpe, F, Farmer, A, McCarthy, M, Gloyn, A
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2010

Geahča maid

Maturity onset diabetes of the young due to HNF1A variants in Croatia
Dahkki: Pavić, T, et al.
Almmustuhtton: (2018)

Identification and assessment of glycan profiles as a biomarker for maturity onset diabetes of the young (MODY) due to hepatocyte nuclear factor 1 alpha (HNF1A) mutations
Dahkki: Gloyn, A, et al.
Almmustuhtton: (2011)

Evaluation of high sensitivity C-reactive protein as a screening tool for detecting young South Asians with maturity-onset diabetes of the young due to HNF1A mutations
Dahkki: Mughal, SA, et al.
Almmustuhtton: (2013)

Use of high sensitivity C-reactive protein and DG9-glycan index for differential diagnosis of maturity-onset diabetes of the young due to HNF1A mutations in young adults
Dahkki: Mughal, SA, et al.
Almmustuhtton: (2013)

Extending criteria for genetic testing increases diagnosis of maturity-onset diabetes of the young
Dahkki: Thanabalasingham, G, et al.
Almmustuhtton: (2010)

Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
Dahkki: Gloyn, A, et al.
Almmustuhtton: (2012)

Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
Dahkki: Mughal, SA, et al.
Almmustuhtton: (2013)

Diagnosis and management of maturity onset diabetes of the young (MODY).
Dahkki: Thanabalasingham, G, et al.
Almmustuhtton: (2011)

Diagnosis and management of maturity onset diabetes of the young (MODY).
Dahkki: Thanabalasingham, G, et al.
Almmustuhtton: (2011)

Diagnosis and management of maturity onset diabetes of the young (MODY)
Dahkki: Thanabalasingham, G, et al.
Almmustuhtton: (2011)

Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
Dahkki: Anna L Gloyn, et al.
Almmustuhtton: (2012-01-01)

Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
Dahkki: Thanabalasingham, G, et al.
Almmustuhtton: (2012)

Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
Dahkki: Juszczak, A, et al.
Almmustuhtton: (2018)

New HNF-1α nonsense mutation causes maturity-onset diabetes of the young type 3
Dahkki: Viviane Nogaroto, et al.
Almmustuhtton: (2011-01-01)

New HNF-1α nonsense mutation causes maturity-onset diabetes of the young type 3
Dahkki: Viviane Nogaroto, et al.
Almmustuhtton: (2011-01-01)

Assessment and translation of novel biomarkers for diagnosis of maturity onset diabetes of the young due to HNF1A variants
Dahkki: Juszczak, A
Almmustuhtton: (2018)

Coinheritance of HNF1A and glucokinase variants in maturity-onset diabetes of the young
Dahkki: Daisuke Watanabe, et al.
Almmustuhtton: (2024-08-01)

De novo HNF1A mutation of young maturity-onset diabetes 3 of a young girl—Case report
Dahkki: Haoran Peng, et al.
Almmustuhtton: (2023-02-01)

Assessment of the pathogenicity of the previously reported D526N Hepatocyte Nuclear factor-1 alpha (HNF1A) variant using a combined genetic, in silico and functional approach
Dahkki: Hassanali, N, et al.
Almmustuhtton: (2013)

Maturity-onset diabetes of the young due to gene mutation
Dahkki: Hae In Lee, et al.
Almmustuhtton: (2023-12-01)

Maturity onset diabetes of the young and fibrin-related thrombosis risk
Dahkki: Sagar, RC, et al.
Almmustuhtton: (2020)

A Novel De Novo Missense Mutation in HNF4A Resulting in Sulfonylurea-Responsive Maturity-onset Diabetes of the Young
Dahkki: Sezer Acar, et al.
Almmustuhtton: (2018-09-01)

Identification and precision therapy for three maturity-onset diabetes of the young (MODY) families caused by mutations in the HNF4A gene
Dahkki: Juan Zhang, et al.
Almmustuhtton: (2023-08-01)

Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
Dahkki: Gloyn, A
Almmustuhtton: (2003)

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
Dahkki: McDonald, T, et al.
Almmustuhtton: (2011)

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
Dahkki: McDonald, T, et al.
Almmustuhtton: (2011)

Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes.
Dahkki: Harries, L, et al.
Almmustuhtton: (2009)

Differences in thrombotic and inflammatory markers comparing subjects with maturity onset diabetes of the young and type 2 diabetes
Dahkki: Bottomley, M, et al.
Almmustuhtton: (2010)

GAD‐65 antibodies in a case of HNF1A‐Maturity‐Onset Diabetes of the Young: Double diabetes?
Dahkki: Åke Sjöholm
Almmustuhtton: (2021-06-01)

A novel splice-site mutation of the HNF1B gene in a family with maturity onset diabetes of the young type 5 (MODY5)
Dahkki: Yuki Fujita, et al.
Almmustuhtton: (2020-09-01)

Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes.
Dahkki: Lorna W Harries, et al.
Almmustuhtton: (2009-11-01)

Early Onset of Mody5 Due to Haploinsufficiency of HNF1B
Dahkki: Carmen Bustamante, MD, et al.
Almmustuhtton: (2020-09-01)

Maturity-onset diabetes of the young secondary to HNF1B variants (HNF1B-MODY): a series of 10 patients from a single diabetes center
Dahkki: Sara Amaral, et al.
Almmustuhtton: (2023-02-01)

Identification of a novel hepatocyte nuclear factor-1 alpha (HNF1A) variant in maturity onset diabetes of the young type 3 (HNF1A-MODY)
Dahkki: Megha Verma, et al.
Almmustuhtton: (2022-04-01)

HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey
Dahkki: Selvihan Beysel, et al.
Almmustuhtton: (2019-05-01)

The role of the HNF4alpha enhancer in type 2 diabetes.
Dahkki: Mitchell, S, et al.
Almmustuhtton: (2002)

The role of the HNF4α enhancer in type 2 diabetes variants of the HNF4α enhancer are not a common cause of susceptibility to type 2 diabetes
Dahkki: Mitchell, S, et al.
Almmustuhtton: (2002)

Maturity‐Onset Diabetes of the Young (MODY) With HNF1B p.Glu105Lys Mutation Achieving Significant Insulin Reduction on Tirzepatide: A Case Report
Dahkki: Mihiro Sue, et al.
Almmustuhtton: (2025-02-01)

Maturity-onset diabetes of the young type 5 a MULTISYSTEMIC disease: a CASE report of a novel mutation in the HNF1B gene and literature review
Dahkki: Juan Camilo Mateus, et al.
Almmustuhtton: (2020-08-01)

Identification of novel variants in HNF1-alpha gene in maturity onset diabetes in young adults (MODY) subjects of Eastern India
Dahkki: Chaitry Ghosal, et al.
Almmustuhtton: (2013-01-01)